drugset / Trial / NCT00611507

A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric Cancer

NCT00611507 ↗

Phase 2 Completed 21 enrolled Sanofi
NaSingle-groupOpen-labelTreatment

Summary

This phase II trial will evaluate, in first line advanced or metastatic gastric cancer, the efficacy and tolerance of another oxaliplatin, 5FU bolus combination already tested in advanced colorectal cancer

Timeline

Start
2002-11
Primary completion
—
Completion
2004-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Leucovorin Small molecule 20 mg/m2 —
Subject Oxaliplatin Small molecule 85 mg/m2 Intravenous
Subject fluorouracil Small molecule 500 mg/m2 Intravenous

Indications